KXK: Source, Brachytherapy, Radionuclide

Product code KXK, “Source, Brachytherapy, Radionuclide” in FDA's classification database, is a Class II device type under 21 CFR 892.5730 (radionuclide brachytherapy source), reviewed by FDA's Radiology panel. FDA's 510(k) database lists 151 clearances under KXK, 37 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
KXK
Regulation
21 CFR 892.5730
Class
II
Panel
Radiology
Clearances
151
Most recent
Dec 5, 2025
Median review, last 2 years
218 days
Third-party review
Not eligible
Implant
Yes

What it covers

A radionuclide brachytherapy source is a device that consists of a radionuclide which may be enclosed in a sealed container made of gold, titanium, stainless steel, or platinum and intended for medical purposes to be placed onto a body surface or into a body cavity or tissue as a source of nuclear radiation for therapy.

The identification in 21 CFR 892.5730, radionuclide brachytherapy source. FDA gives KXK no definition of its own, so the regulation’s describes it.

FDA flags KXK devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K252296OncoPatchOncopatch, Inc.Dec 5, 2025Traditional
K242818IsoSphereIsoaid, LLCJul 15, 2025Traditional
K223465RadianceTx Radionuclide Brachytherapy SourceRadiance Therapeutics, Inc.Jan 11, 2023Traditional
K221539GammaTileGt Medical TechnologiesNov 9, 2022Traditional
K202267Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge NeedlesIsoray Medical, Inc.Dec 31, 2020Traditional
K193602LV Liberty Vision Model 1 90Yttrium Brachytherapy SourceLv Liberty Vision CorporationMay 29, 2020Special
K190839GammaTileGt Medical TechnologiesJan 23, 2020Traditional
K191324CivaDermCivatech Oncology, Inc.Sep 20, 2019Traditional
K190296GammaTileGt Medical TechnologiesMar 13, 2019Special
K180515GammaTileIsoray Medical, Inc.Jul 6, 2018Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 151 with a free account)

Clearances by year

37 KXK 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20252218
2023155
20221166
20203158
2019279
20181129
2017291
2016449
2015268
2014896
20133127
20123109
2011594

Who submits

25 applicants cleared a KXK device since 2011. 97% of the clearances went to applicants in United States, then Germany (3%). By type: Traditional 78%, Special 14% and Abbreviated 8%.

ApplicantClearances since 2011
Source Production and Equipment Co., Inc.4
Gt Medical Technologies3
Isoaid, LLC3
Isoray Medical, Inc.3
C4 Imaging, LLC2
Civatech Oncology, Inc.2
Salutaris Medical Devices, Inc.2
Advanced Nuclide Technologies, LLC1

How FDA classifies it

Class II (special controls). A prostate seeding kit intended for use with a radionuclide brachytherapy source only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

From 21 CFR 892.5730. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 892.5730 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KXK clearances declared.

Ask about KXK

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about KXK

What is FDA product code KXK?

Product code KXK, “Source, Brachytherapy, Radionuclide” in FDA's classification database, is a Class II device type under 21 CFR 892.5730 (radionuclide brachytherapy source), reviewed by FDA's Radiology panel. FDA's 510(k) database lists 151 clearances under KXK, 37 of them since 2011.

How many 510(k) clearances are there under KXK?

FDA’s 510(k) database listed 151 clearances under KXK as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Dec 5, 2025. The Predicate Finder searches the live database.

How long does FDA take to clear a KXK 510(k)?

For the 2 KXK clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 218 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most KXK clearances?

Since 2011: Source Production and Equipment Co., Inc. (4), Gt Medical Technologies (3), Isoaid, LLC (3), Isoray Medical, Inc. (3) and C4 Imaging, LLC (2). 25 applicants have cleared a KXK device in that time.

Sources

  1. FDA product classification: KXK · Product Classification database
  2. 21 CFR 892.5730: Radionuclide brachytherapy source · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for KXK · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow KXKGet an email when FDA clears, recalls or publishes guidance for KXK devices.

Know what FDA already cleared.